Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer
JAMA Network Open · 2026
DOI: 10.1001/jamanetworkopen.2026.35610 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2026. Verfasst von Tommaso Dall'Olio und 28 weiteren Autor:innen. Beteiligte Einrichtung: University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatic Intraductal Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Pancreatic cystic lesions are common during surveillance of individuals at hereditary risk for pancreatic cancer, but whether their incidence and progression differ across genetic risk groups remains uncertain.
Objective
To compare the incidence, morphologic characteristics, and progression of presumed intraductal papillary mucinous neoplasms (IPMNs) in individuals at high risk of PC across hereditary risk groups. Design, Setting, and Participants This multicenter cohort study was conducted from January 2016 to December 2025 at 25 centers participating in the Italian Registry of Families at Risk of Pancreatic Cancer. Participants were individuals undergoing pancreatic surveillance with magnetic resonance imaging with cholangiopancreatography and/or endoscopic ultrasonography. Exposure Familial pancreatic cancer without pathogenic germline variants vs pathogenic germline variant (PGV) carrier status, further grouped into 3 predefined categories: PGV1 (Peutz-Jeghers syndrome or CDKN2A sequence variant carriers), PGV2 ( BRCA2 or ATM variant carriers), and PGV3 (Lynch syndrome–associated genes or BRCA1 or PALB2 variant carriers). Main Outcomes and Measures Cumulative incidence of presumed IPMNs, longitudinal changes in index cyst diameter and main pancreatic duct diameter, and progression to worrisome features or high-risk stigmata. Multivariable Cox proportional hazards regression was used to estimate hazard ratios (HRs) for incident IPMNs, adjusted for hereditary risk, age, sex, body mass index, tobacco smoking status, and diabetes.
Results
Among 1688 high-risk individuals (median age, 56 years [IQR, 50-64 years]; 1055 women [62.5%]), 496 (29.4%) had a presumed IPMN. Median follow-up from enrollment was 17 months (IQR, 0-36 months). A total of 1298 participants (76.9%) did not have a presumed pancreatic cyst at baseline, and 124 (9.6%) of these participants developed an incident lesion during follow-up. In the complete-case multivariable analysis of 1245 participants and 123 events, PGV1 (adjusted HR [AHR], 1.82; 95% CI, 0.97-3.43), PGV2 (AHR, 0.81; 95% CI, 0.45-1.45), and PGV3 (AHR, 0.70; 95% CI, 0.34-1.44) were not associated with incident cyst development compared with FPC, whereas older age was associated with higher incidence (AHR per year, 1.04; 95% CI, 1.02-1.05). Longitudinal trajectories of cyst growth (time × group interaction: χ 2 = 14.4; df = 15; P = .49) and main pancreatic duct diameter (time × group interaction: χ 2 = 4.35; df = 15; P > .99) did not differ significantly across groups, and progression to worrisome features or high-risk stigmata was infrequent (13 patients [2.6%]). Conclusions and Relevance In this multicenter cohort study of individuals at high risk of PC who were undergoing pancreatic surveillance, the incidence and short-term progression of presumed IPMNs did not differ significantly across hereditary risk groups, whereas older age was associated with incident cyst development. Longer follow-up appears to be needed to assess potential gene-specific differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Verona, Verona, Italy.
- Pancreatic Surgery Unit, Department of Surgery, University of Verona Hospital Trust, Verona, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
- Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.
- Hepato-Pancreato-Biliary Unit, Department of Surgical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Zitieren
APA
Dall'Olio, T., Capurso, G., Terrin, M., De Luca, R., Coluccio, C., Arcangeli, V., Milanetto, A. C., Butturini, G., Fantin, A., Barresi, L., De Marchi, G., Galli, A., Di Marco, M., Panzuto, F., Sassatelli, R., Ricci, C., Di Matteo, F. M., Spinelli, E., Dal Buono, A., …, & Italian Registry of Families at Risk of Pancreatic Cancer Study Group (2026). Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.35610
Vancouver
Dall'Olio T, Capurso G, Terrin M, De Luca R, Coluccio C, Arcangeli V, et al. Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.35610
BibTeX
@article{DallOlio2026,
author = {Dall'Olio, Tommaso and Capurso, Gabriele and Terrin, Maria and De Luca, Raffaele and Coluccio, Chiara and Arcangeli, Valentina and Milanetto, Anna Caterina and Butturini, Giovanni and Fantin, Alberto and Barresi, Luca and De Marchi, Giulia and Galli, Andrea and Di Marco, Marco and Panzuto, Francesco and Sassatelli, Romano and Ricci, Claudio and Di Matteo, Francesco Maria and Spinelli, Elide and Dal Buono, Arianna and Patruno, Margherita and Cavestro, Giulia Martina and Venturini, Elisa and Arcidiacono, Paolo Giorgio and Salvia, Roberto and Falconi, Massimo and Carrara, Silvia and Archibugi, Livia and Paiella, Salvatore and Italian Registry of Families at Risk of Pancreatic Cancer Study Group, Italian Registry of Families at Risk of Pancreatic Cancer Study Group},
title = {Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer},
journal = {JAMA Network Open},
year = {2026},
doi = {10.1001/jamanetworkopen.2026.35610}
}
EUVIMED